Expert Panel Wants to See Action on Excessive Yakkasa, No Direction on Buffer Zone: Draft Report

June 5, 2023
Japan should work to address excessive and unevenly distributed yakkasa , or the difference between NHI and market prices of pharmaceuticals, to ensure an appropriate environment for drug transactions, a key health ministry panel urges in a draft report obtained...read more